MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2022 International Congress

September 15-18, 2022. Madrid, Spain.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Execution of scientific tractography for presurgical preparation of area seizing abrasions: A study through the acquisition plus post-processing techniques contrasted to investigational revisions

    V. Rama Raju, G. Ramaraju, V. Ramaraju (Hyderabad, India)

  • Exenatide protects iPSC-derived dopaminergic neurons with A53T mutation through restoration of insulin signaling

    D. Athauda, J. Evans, A. Wernick, G. Virdi, M. Choi, K. D'Sa, Z. Shadman, N. Greig, T. Foltynie, S. Gandhi (London, United Kingdom)

  • Exosomes from human dental pulp stem cells as a cell-free drug delivery vehicle in vitro and in vivo chronic PD rat model through the intranasal route targeting efficacy & bio-distribution.

    I. Datta, A. Kaushal, K. Mondal (Bangalore, India)

  • Expanding the armamentarium of clinical use of apomorphine in movement disorders.

    S. Bansal, JR. Chai, M. Jog (London, Canada)

  • Expanding the services of Neurogenetic Clinic – Lessons learnt from Cerebellar Ataxia cohort

    P. Ponger, D. Barel, A. Mory, A. Kurolap, A. Bar David, H. Feldman Baris, N. Giladi, T. Gurevich (Tel Aviv, Israel)

  • Expectations of DBS: the patient’s perspective

    E. Sanesteban Beceiro, V. Gómez Mayordomo, A. Fernández Revuelta, C. Fernández García, R. García-Ramos, E. López Valdés, F. Alonso Frech (Madrid, Spain)

  • Experience with apomorphine infusion cartridge in France – evaluation of patient and healthcare team benefits

    M. Vérin, M. Demais (Rennes, France)

  • Explorative study of analysis of the role of NFL and IGF1 in Indian patients with PSP and its clinical correlation.

    R. Yelamanchi, S. Dey, R. Yadav, P. Pal, M. Debnath, V. Holla, N. Kamble, S. T N, T. Mullapudi (Bangalore, India)

  • Exploratory analysis of the effect of delayed-start prasinezumab on motor sign progression measured with the Roche PD Mobile Application v2: PASADENA Phase II Parts 1 and 2

    K. Taylor, F. Lipsmeier, E. Volkova-Volkmar, M. Scelsi, L. Essioux, A. Monnet, B. van Lier, H. Svoboda, T. Kustermann, W. Zago, T. Nikolcheva, R. Postuma, G. Pagano, M. Lindemann (Basel, Switzerland)

  • Exploratory delayed-start analysis of PASADENA evaluating the efficacy of prasinezumab on motor progression and motor complications in early-stage Parkinson’s disease

    G. Pagano, S. Zanigni, A. Monnet, K. Taylor, A. Hahn, T. Simuni, K. Marek, R. Postuma, N. Pavese, F. Stocchi, H. Svoboda, P. Fontoura, R. Doody, G. Kerchner, A. Bonni, T. Nikolcheva (Basel, Switzerland)

  • « Previous Page
  • 1
  • …
  • 58
  • 59
  • 60
  • 61
  • 62
  • …
  • 153
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley